From high-tech cancer fighters to AI-wielding crime busters, these are some of the most innovative firms on the ASX
Special Report: A recent lunch put together in Sydney by Jane Morgan Management and Éthica Capital saw a number of the ASX’s most innovative biotech [more…]
Emerging Chilean explorer Tesoro Gold ‘on the cusp’ of proving a +100kozpa operation at El Zorro
With more than 100,000m of drilling completed and a 1.3Moz gold resource already defined, Tesoro Gold has achieved more than most juniors have since its [more…]
Optiscan and Mayo Clinic join forces for groundbreaking advancement in pathology
Optiscan enters know-how agreement with world-renowned Mayo Clinic for major pathology breakthrough Two organisations working to develop a digital confocal laser endomicroscopic imaging system for [more…]
FREE WHELAN: The Critical Edition
In this Stockhead series, investment manager James Whelan, managing director Barclay Pearce Capital Asset Management, offers his insights on the key investment themes and trends in [more…]
$12,000 copper: Why Anglo’s red metal assets make the rest of it worthwhile
ANZ says copper could hit US$12,000/t to incentivise the construction of new megamines needed for the energy transition The quality and unit costs of Anglo [more…]
Is there finally a bull in the China shop?
A Chinese EV maker ended its Wall Street debut circa 33% higher on Friday. Just where Geely Group’s Zeekr closes this Friday in New York [more…]
MoneyTalks: The hour has come for Regis, Resolute, Paladin and Bannerman
MoneyTalks is Stockhead’s regular recap of the ASX stocks, sectors and trends that fund managers and analysts are looking at right now. Today we hear [more…]
Rise and Shine: Everything you need to know before the ASX opens
Good morning everyone, and welcome to 14 May, 2024 – an important day in history for a few different reasons. On this day in [more…]
AdAlta secures Cell Therapies as cellular immunotherapies manufacturer
AdAlta and Cell Therapies Pty Ltd (CTPL) execute a master services agreement The deal establishes CTPL as AdAlta’s preferred manufacturer of cellular Immunotherapies MSA also [more…]
All spodumene welcome! LU7’s Bécancour lithium refinery design is perfect for processing hub strategy
Testing proves Bécancour refinery design can produce battery-grade lithium carbonate using spodumene from all over the world Second batch of product produced meets battery-grade specifications [more…]
